Document and Entity Information
Document and Entity Information | Nov. 03, 2023 |
Document And Entity Information [Line Items] | |
Amendment Flag | false |
Entity Central Index Key | 0001829802 |
Document Type | 8-K |
Document Period End Date | Nov. 03, 2023 |
Entity Registrant Name | Sensei Biotherapeutics, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-39980 |
Entity Tax Identification Number | 83-1863385 |
Entity Address, Address Line One | 1405 Research Blvd |
Entity Address, Address Line Two | Suite 125 |
Entity Address, City or Town | Rockville |
Entity Address, State or Province | MD |
Entity Address, Postal Zip Code | 20850 |
City Area Code | 240 |
Local Phone Number | 243-8000 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Common Stock [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Common Stock |
Trading Symbol | SNSE |
Security Exchange Name | NASDAQ |
Series A Preferred Stock [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Series A Preferred Stock Purchase Rights |
Security Exchange Name | NASDAQ |